-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 GZUSeaELYp77q6Gn+SVe6xYtNx75ThV32ykLpsVXgEwgt9mPPVSCIsaJk3juFuZA
 liwxqJ7OP9m3Wac/7FxMMQ==

<SEC-DOCUMENT>0000927946-04-000250.txt : 20041208
<SEC-HEADER>0000927946-04-000250.hdr.sgml : 20041208
<ACCEPTANCE-DATETIME>20041208162416
ACCESSION NUMBER:		0000927946-04-000250
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20041208
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20041208
DATE AS OF CHANGE:		20041208

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		041191137

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETT
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bas8k.htm
<DESCRIPTION>BIOANALYTICAL SYSTEMS - 8K
<TEXT>
<HTML>
<HEAD>
<TITLE>Bioanalytical Systems, Inc. 8K</TITLE>
</HEAD>
<BODY>


<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" size=2>
UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549<BR>
<BR>
FORM 8-K<BR>
<BR>
CURRENT REPORT<BR>
<BR>

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934<BR>
<BR>
Date of Report (Date of earliest event reported): December 8, 2004
</font></P>
<BR>


<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>

<TD align=center colspan=3 WIDTH=33%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
BIOANALYTICAL SYSTEMS, INC.<hr width=250>
(Exact name of registrant as specified in its charter)
</FONT></TD></tr>

<TR>
<TD>&nbsp;</td>
</TR>



<TR VALIGN=TOP>
<TD align=center WIDTH=34%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Indiana<HR width=100>
(State or other<BR>
jurisdiction of<BR>
incorporation or<BR>
organization)</FONT></TD>

<TD align=center WIDTH=33%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
0-23357<hR width=150>
(Commission File Number)
</FONT></TD>

<TD align=center WIDTH=33%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
35-1345024<HR width=150>
(I.R.S. Employer<BR>
Identification No.)</FONT></TD>
</TR>
</TABLE>
<BR>



<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD align=center WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
2701 KENT AVENUE<BR>
WEST LAFAYETTE, INDIANA<HR width=250>
(Address of principal executive offices)
</FONT></TD>
<TD align=center WIDTH=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
47906-1382<HR width=100>
(Zip Code)
</FONT></TD>
</TR>
</TABLE>
<BR>
<BR>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" size=2>
Registrant's telephone number, including area code:&nbsp;&nbsp;(765)
463-4527</font></P>



<PAGE>



<P ALIGN=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Item 1.01.&nbsp;&nbsp;&nbsp;&nbsp;Entry into a Material Definitive Agreement.</FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation" -->
<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
On December 8, 2004, Bioanalytical Systems, Inc. (the &#147;Company&#148;)
issued a press release announcing that the Company has reached an agreement
providing for the sale and leaseback of the building that currently houses its
clinical research facility in downtown Baltimore, Maryland. BASi will receive
$6.5 million in cash from the transaction and will lease 85% of the building for
three years at near market rate. Proceeds from the transaction will be used to
reduce debt and increase working capital. A purchase agreement was executed, due
diligence satisfactorily completed, and a nonrefundable $1,000,000 deposit is in
escrow. The transaction is scheduled to close in early January, 2005.
</FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation" -->
<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
The full text of the press release is furnished as exhibit 99.1 to this Form 8-K
and is incorporated herein by reference. </FONT></P>

<!-- MARKER FORMAT-SHEET="Head Left-TNR" FSL="Workstation" -->
<A NAME=A001></A>
<P ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Not applicable.</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Not applicable. </FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Default" -->
<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Exhibits </FONT></P>

<P ALIGN=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99.1&nbsp;&nbsp;&nbsp;&nbsp;
Bioanalytical Systems, Inc. press release, issued December 8, 2004.</FONT></P>

<PAGE>




<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<B>SIGNATURES</B></FONT></P>
<BR>

<P ALIGN=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</FONT></P>

<!-- MARKER FORMAT-SHEET="Signature (Single)" FSL="Workstation" -->
<TABLE WIDTH=100% CELLSPACING=0 CELLPADDING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=60%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<BR>
<BR>
<BR>
<BR>
<BR>
Date:&nbsp;&nbsp;December 8, 2004</FONT></TD>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Bioanalytical Systems, Inc.<BR>
<BR>
<BR>
<BR>
By:&nbsp;&nbsp;/s/&nbsp;Michael R. Cox<hr>
Michael R. Cox<BR>
VP-Finance, Chief Financial Officer and Treasurer</FONT></TD>
</TR>
</TABLE>
<BR>

<PAGE>





<!-- MARKER FORMAT-SHEET="Heading Center Bold" FSL="Workstation" -->
<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>Exhibit Index</U></FONT></H1>

<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=10%><div align=center><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>Exhibit No.</U><BR>
<BR>
99.1</FONT></div></TD>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>Description</U><BR>
<BR>
Bioanalytical Systems, Inc. press release, issued December 8, 2004.
</FONT></TD>
</TR>
</TABLE>
<BR>



</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>exhibit991.htm
<DESCRIPTION>EXHIBIT 99.1 - PRESS RELEASE DATED 12/08/2004
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 99.1 - Bioanalytical Systems, Inc.</TITLE>
</HEAD>
<BODY>

<P align=center><FONT FACE="Times New Roman, Times, Serif" size=2>
<B><u>Exhibit 99.1</u></B></font></P>
<BR>

<P align=right><FONT FACE="Times New Roman, Times, Serif" size=1>
<B>FOR MORE INFORMATION:</B><BR>
Bioanalytical Systems, Inc.<BR>
Michael R. Cox, 765-497-5829<BR>
<U>mcox@bioanalytical.com</U><BR>
</font></P>
<BR>



<P align=center><FONT FACE="Times New Roman, Times, Serif" size=2>
<B>Bioanalytical Systems, Inc. Announces $6.5 million Sale-leaseback of
Baltimore Facility</B></font></P>


<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
WEST LAFAYETTE, Ind., December 8, 2004&#151;&nbsp;Bioanalytical Systems, Inc.
(Nasdaq:BASI) today announced that it has reached an agreement providing for the
sale and leaseback of the building that currently houses its clinical research
facility in downtown Baltimore, Maryland. BASi will receive $6.5 million in cash
from the transaction and will lease 85% of the building for three years at near
market rate. Proceeds from the transaction will be used to reduce debt and
increase working capital. A purchase agreement was executed, due diligence
satisfactorily completed, and a nonrefundable $1,000,000 deposit is in escrow.
The transaction is scheduled to close in early January, 2005.</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
Bioanalytical Systems, Inc. is a pharmaceutical development company providing
contract research services and monitoring instruments to the world&#146;s leading
drug development and medical device companies. BASi focuses on developing
innovative services and products that increase efficiency and reduce costs
associated with taking new drugs to market. Visit <U>www.bioanalytical.com</U>
for more about BASi.</font></P>
<BR>
<BR>


<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" size=1>
<I>This release contains forward-looking statements that are subject to risks and
uncertainties including, but not limited to,<BR>
risks and uncertainties related to the development of products and services,
changes in technology, industry standards and regulatory<BR>
standards, and various market and operating
risks detailed in the company&#146;s filings with the Securities and Exchange
Commission.</I></font></P>


<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" size=2>
#&nbsp;#&nbsp;#&nbsp;#&nbsp;#</font></P>


</BODY>
</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
